rxstat › Shortages › Epinephrine
Epinephrine shortage status
Partial shortage
Source: Health Canada shortage reports · Updated Jul 9, 2026
Some Epinephrine products are in shortage in Canada (1 of 12 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Aug 30, 2026.
Est. full return
Aug 30, 2026
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.
Reports by product
Active shortageEPINEPHRINE INJECTION USP
1MG · SOLUTION · PFIZER CANADA ULC
DIN 00721891 · since ?, est. end Aug 30, 2026 · Disruption of the manufacture of the drug.
ResolvedALLERJECT
0.3MG · SOLUTION · VALEO PHARMA INC
DIN 02382067 · ended May 14, 2025 · Other (Please describe in comments)
ResolvedALLERJECT
0.15MG · SOLUTION · VALEO PHARMA INC
DIN 02382059 · ended Aug 1, 2024 · Other (Please describe in comments)
DiscontinuedEMERADE
0.3MG · SOLUTION · BAUSCH HEALTH, CANADA INC.
DIN 02458446
DiscontinuedEMERADE
0.5MG · SOLUTION · BAUSCH HEALTH, CANADA INC.
DIN 02458454
ResolvedEMERADE
0.5MG · SOLUTION · BAUSCH HEALTH, CANADA INC.
DIN 02458454 · ended Dec 18, 2025 · Other (Please describe in comments)
ResolvedEMERADE
0.3MG · SOLUTION · BAUSCH HEALTH, CANADA INC.
DIN 02458446 · ended Dec 18, 2025 · Other (Please describe in comments)
ResolvedEPINEPHRINE INJECTION
1MG · SOLUTION · LABORATOIRE AGUETTANT
DIN 02521148 · ended Dec 14, 2024 · Demand increase for the drug.
DiscontinuedEPINEPHRINE INJECTION USP
1MG · SOLUTION · PFIZER CANADA ULC
DIN 00710814
ResolvedEPINEPHRINE INJECTION USP
1MG · SOLUTION · PFIZER CANADA ULC
DIN 00710814 · ended Aug 18, 2025 · Disruption of the manufacture of the drug.
ResolvedEPINEPHRINE INJECTION USP
1MG · SOLUTION · HIKMA CANADA LIMITED
DIN 02435810 · ended May 30, 2025 · Shortage of an inactive ingredient or component.
ResolvedEPINEPHRINE INJECTION USP
1MG · SOLUTION · PFIZER CANADA ULC
DIN 00721891 · ended Jan 31, 2025 · Disruption of the manufacture of the drug.
Showing 12 of 44 reports. All reports are on file with Health Canada.
What's happening
Epinephrine is currently affected by an active shortage report filed with Health Canada by PFIZER CANADA ULC.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Epinephrine is classified under “CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES” (ATC C01CA).
Recent changes
Common questions
When will Epinephrine be back in stock in Canada?
The latest manufacturer estimate is Aug 30, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Epinephrine in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Guides: what to do when your medication is in shortage · how to read shortage reports
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.